Skip to Main Content

Paper Details

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
JAMA Neurol
30
2023
Author NameAffiliation
Klaus BergerInstitute of Epidemiology and Social Medicine, University of Munster
Fredrik PiehlKarolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital
Fredrik PiehlCenter for Neurology, Stockholm Health Services
David LeppertUniversity Hospital and University of Basel
David LeppertDepartments of Biomedicine and Clinical Research, University Hospital and University of Basel
David LeppertResearch Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital and University of Basel
  • 1 - 6

Datasets